Physician profile
Eric Rudnick
NPI 1821462938
$3,539.99
in general payments reported to CMS, 2019-2025
13 companies · $1,015 in 2025
The $1,015 reported for 2025 was more than what 95% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $493 · 2020: $490 · 2021: $437 · 2022: $142 · 2023: $232 · 2024: $731 · 2025: $1,015.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,978.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,977.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,747.88 | 2019-2025 | Grafix Pl, Collagenase Santyl, Regranex |
| Organogenesis INC. | $740.60 | 2019-2025 | Apligraf, Puraply Wound Matrix, Nushield |
| Mimedx Group, INC. | $341.55 | 2024-2025 | |
| Tactile Systems Technology INC | $166.63 | 2022-2025 | Nimbl, Flexitouch Plus |
| Glaxosmithkline, LLC. | $164.07 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $125.98 | 2024-2025 | Nuzyra |
| Urgo Medical North America, LLC | $109.22 | 2024-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Osiris Therapeutics INC. | $33.86 | 2019 | |
| Kci USA, INC. | $32.92 | 2021 | |
| Kerecis Limited | $24.07 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Medline Industries LP | $19.45 | 2023 | |
| Apria Healthcare LLC | $17.41 | 2021 | |
| Hartmann USA, INC. | $16.35 | 2023 | Zetuvit Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Rudnick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.